140 results
Page 2 of 7
424B3
382dn6suilhac5q0ex
2 Feb 24
Prospectus supplement
12:00am
DEF 14C
tuaeg
29 Jan 24
Information statement
8:00am
PRE 14C
uuz capbs8pb03fjp
17 Jan 24
Preliminary information
5:05pm
8-K
mmydh
12 Jan 24
Submission of Matters to a Vote of Security Holders
6:01am
8-K
EX-4.1
z2ghij xc8ea78a199i
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
u7g1mx1l6hpumwfjh
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.2
s6i3dyvz q2
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
oy1bql71i mgfqwu8e81
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
vm87ni
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.1
9g79h5i
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.2
st3hf6u07f 6c4k9
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
aoo9 f4qqy
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.3
nv9ia1 feuoc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
4ar2ue9259u90i vptc8
2 Nov 23
Prospectus supplement with pricing info
9:00am